Source: EURLEX
Language: en
Format: md

|  |  |  |
| --- | --- | --- |
| European flag | Official Journal  of the European Union | EN  C series |

---

|  |  |  |
| --- | --- | --- |
|  | C/2025/743 | 10.2.2025 |

Action brought on 13 December 2024 – +pharma arzneimittel v EUIPO – PlusQuam Pharma (PlusQuam +PHARMA)

(Case T-645/24)

(C/2025/743)

Language in which the application was lodged: German

Parties

Applicant: +pharma arzneimittel GmbH (Graz, Austria) (represented by: L. Wiltschek and D. Plasser, lawyers)

Defendant: European Union Intellectual Property Office

Other party to the proceedings before the Board of Appeal: PlusQuam Pharma, SL (Badajoz, Spain)

Details of the proceedings before EUIPO

Applicant for the trade mark at issue: Other party to the proceedings before the Board of Appeal

Trade mark at issue: Application for EU word mark PlusQuam +PHARMA – Application No 18 730 938

Proceedings before EUIPO: Opposition proceedings

Contested decision: Decision of the Second Board of Appeal of EUIPO of 7 November 2024 in Case R 1217/2024-2

Form of order sought

The applicant claims that the Court should:

|  |  |
| --- | --- |
| — | amend the contested decision so that the opposition filed against EU trade mark application No 18 730 938 ‘PlusQuam +PHARMA’ is upheld in its entirety; in the alternative, annul the contested decision; |

|  |  |
| --- | --- |
| — | order EUIPO to pay the costs of the proceedings before the Court and before the Board of Appeal; |

|  |  |
| --- | --- |
| — | order the intervener to pay the costs incurred in the proceedings before the Opposition Division. |

Pleas in law

|  |  |
| --- | --- |
| — | Infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council; |

|  |  |
| --- | --- |
| — | Infringement of Article 8(5) of Regulation (EU) 2017/1001 of the European Parliament and of the Council. |

---

[Top](#document1)